微信小陈
微信小章
产品简介
购买须知
| 产品名称： | MC/CAR-Z2 derivative of MC/CAR (ATCC CRL-8083) (ATCC® CRL-8147™) |
|---|---|
| 商品货号： | TS211527 |
| Organism： | Homo sapiens, human |
| Cell Type： | B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | plasmacytoma; myeloma |
| Age： | 81 years |
| Gender： | male |
| Ethnicity： | Caucasian |
| Applications： | Resistant to 8-azaguanine. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Clinical Data： | male Caucasian 81 years |
| Comments： | Resistant to 8-azaguanine. Will die in HAT medium within 15 to 20 days. |
| Complete Growth Medium： | RPMI 1640 medium with 0.02 mg/ml 8-azaguanine, 80%; fetal bovine serum, 20%
|
| Subculturing： | Medium Renewal: 2 to 3 times per week Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 5 X 10 exp5 cells/ml and maintain between 4 X 10 exp5 and 5 X 10 exp6 cells/ml. |
| Population Doubling Time： | 20 to 24 hrs |